In our final installment of posts that highlights the new features of the iDSI website, Dr. Ryan Li introduces the Resources section – focusing on the principles for developing clinical quality standards in Low and Middle Income Countries (LMICs). I remember very vividly two of the hospitals I visited in Vietnam, during my first field trip as a global …
Exploring Evidence for Supporting Government Investment in the Peritoneal Dialysis First Policy
Renal replacement therapy (RRT) is the only life-saving type of treatment for end-stage renal disease (ESRD) patients. There are three types of RRT: kidney transplantation, haemodialysis, and peritoneal dialysis. To respond to the growing burden of non-communicable diseases including chronic kidney disease, RRT is now a national issue to consider for government investment under Universal Health Coverage. However, universal access …
Dr Suwit Wibulpolprasert delivers inaugural Global Health and Development lecture at Imperial College
The newly formed Global Health and Development Group at Imperial College London welcomed Thai general practitioner and public health policy advocate, Dr Suwit Wibulpolprasert as the first guest speaker for a Global Health and Development lecture series, the first of its kind at the College. Dr Suwit spoke about the Thai experience of achieving universal access to affordable quality healthcare, outlining some of the challenges faced …
PMAC 2016 report published
The Prince Mahidol Award Conference (PMAC) 2016 report is now available to download from the PMAC website, along with the program, and materials from the plenaries and panels. The theme for this year’s conference was Priority Setting for Universal Health Coverage (UHC). Discussion focused on how countries can make “better decisions about priorities in the context of UHC, regardless of how rich …
Off-Label Use of Drugs and Access to Medicines for All: A Thailand Example – Asia Unbound blog
Yanzhong Huang’s blog, Off-Label Use of Drugs and Access to Medicines for All: A Thailand Example, reflects on the role of off-label drugs for improving affordable access to innovative medicines and facilitating progress towards UHC, highlighting the Thai experience of bevacizumab. “up to 68 percent of out of pocket health costs in resource-limited countries is for medication… inclusion of off-label drugs in the UHC …
Thailand
New publication: Thailand QOF project December 2016 A paper summarising iDSI partners’ work on the Thailand QOF project has been published on F1000 Research. Read the article here: https://f1000research.com/articles/5-2700/v1 NICE International supporting Thailand to review its QOF programme July 2015 NICE International, together with the National Collaborating Centre for Indicator Development (NCCID) in Birmingham, is helping Thailand review its Quality Outcomes …